These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3158365)
1. Effect of alpha-difluoromethylornithine in lung metastases before and after surgery of primary adenocarcinoma tumors in mice. Klein S; Miret JJ; Algranati ID; de Lustig ES Biol Cell; 1985; 53(1):33-6. PubMed ID: 3158365 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of tumor-operated mice with high doses of alpha-difluoromethylornithine. de Lustig ES; Klein S; Fuchs A; Algranati ID Biol Cell; 1986; 58(3):233-7. PubMed ID: 2952208 [TBL] [Abstract][Full Text] [Related]
3. Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine. Bartholeyns J Eur J Cancer Clin Oncol; 1983 Apr; 19(4):567-72. PubMed ID: 6407845 [TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma. Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502 [TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312 [TBL] [Abstract][Full Text] [Related]
6. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128 [TBL] [Abstract][Full Text] [Related]
7. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Sunkara PS; Rosenberger AL Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers. Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786 [TBL] [Abstract][Full Text] [Related]
9. Effect of tamoxifen and D,L-2-difluoromethylornithine on the growth, ornithine decarboxylase activity and polyamine content of mammary carcinomas induced by 1-methyl-1-nitrosourea. Thompson HJ; Ronan AM; Ritacco KA; Meeker LD Carcinogenesis; 1986 May; 7(5):837-40. PubMed ID: 3084121 [TBL] [Abstract][Full Text] [Related]
10. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine. Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708 [TBL] [Abstract][Full Text] [Related]
11. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells. Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice. Luk GD; Abeloff MD; Griffin CA; Baylin SB Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400 [TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo. Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877 [TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Heston WD; Fleischmann J; Tackett RE; Ratliff TL Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer. Herr HW; Kleinert EL; Relyea NM; Whitmore WF Cancer; 1984 Mar; 53(6):1294-8. PubMed ID: 6420041 [TBL] [Abstract][Full Text] [Related]
16. Polyamines prevent DFMO-mediated inhibition of angiogenesis. Jasnis MA; Klein S; Monte M; Davel L; Sacerdote de Lustig E; Algranati ID Cancer Lett; 1994 Apr; 79(1):39-43. PubMed ID: 7514492 [TBL] [Abstract][Full Text] [Related]
18. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells. Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of mouse mammary adenocarcinoma (EMT6) growth and metastases in mice by a modified form of C-reactive protein. Kresl JJ; Potempa LA; Anderson B; Radosevich JA Tumour Biol; 1999; 20(2):72-87. PubMed ID: 10050106 [TBL] [Abstract][Full Text] [Related]
20. Murine breast cancer mastectomy model that predicts patient outcomes for drug development. Katsuta E; Rashid OM; Takabe K J Surg Res; 2017 Nov; 219():310-318. PubMed ID: 29078898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]